Company / Return on Assets (ROA)
Niagen Bioscience, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
16.3%
FY2025
5-year range
-50.2% / 16.3%
FY2021-FY2025
Trend
+326.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed +326% YoY in FY2025, a notable deviation from the 9-year average annual change of +20%.
Based on SEC 10-K filings.
16.3% in FY2025 with a 5-year CAGR of +100.2%.
Improved from -30.1% to 16.3% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +66.5pp
- 5-Year Change
- +100.2pp
- 10-Year Change
- -
Key checks
Key Insights
- Niagen Bioscience, Inc.'s return on assets (roa) has grown for 3 consecutive years.
- In FY2025, return on assets (roa) increased 326.0% year-over-year.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 16.3% | +326.0% |
| FY2024 | -7.2% | +76.0% |
| FY2023 | -30.1% | +40.0% |
| FY2022 | -50.2% | -45.7% |
| FY2021 | -34.4% | +58.9% |
| FY2020 | -83.8% | -4.9% |
| FY2019 | -79.9% | -196.5% |
| FY2018 | -26.9% | -48.5% |
| FY2017 | -18.1% | -22.4% |
| FY2016 | -14.8% | -0.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026